QScreen AI Announces Strategic Financing to Advance Commercialization Initiatives Across North America

Core Viewpoint - QScreen AI Inc is launching a non-brokered private placement to raise up to C$500,000 by issuing up to 10,000,000 units at a price of C$0.05 per unit, aimed at advancing health screening and employee wellness initiatives [1][3]. Group 1: Private Placement Details - The offering consists of units, each comprising one common share and one half of a common share purchase warrant, with warrants allowing the purchase of one half common share at C$0.15 for 36 months [2]. - If the volume weighted average price of the common shares reaches or exceeds C$0.30 for 10 consecutive trading days, the company may accelerate the expiry date of the warrants [2]. Group 2: Use of Proceeds - Proceeds from the financing will support structured pilot discussions and operational integration planning with select organizations, building on recent engagements in Mexico [3]. - Funds will also be allocated to working capital needs associated with scaling commercialization efforts across healthcare, industrial, and technology sectors [3]. Group 3: Market Interest - The company has received preliminary indications of interest from select investors for participation in the private placement, indicating strong market interest in its commercialization initiatives [4]. Group 4: Company Overview - QScreen AI Inc is an emerging provider of rapid health screening and remote patient care solutions, utilizing proprietary AI technology to analyze physiological data and predict various health issues [5]. - The company's Smarthealth AI stations analyze 19 physiological vital parameters and can assess impairment by drugs or alcohol, fatigue, and mental illnesses [5].